Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
646 participants
INTERVENTIONAL
2002-09-30
2003-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Local Register Study For Major Depression Of Paroxetine Controlled Release
NCT00368303
A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder
NCT00048204
Depression Study In Elderly Patients
NCT00067444
A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant
NCT05109195
Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression)
NCT01371461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
paroxetine CR
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Discontinued a selective serotonin reuptake inhibitor (SSRI)or serotonin-norepinephrine reuptake inhibitor (SNRI) regimen due to intolerability.
* Minimum time frame between last dose of previous antidepressant and initiation of study drug is one week.
* Maximum time frame between last dose of prior antidepressant and initiation of study drug is 2 months.
Exclusion Criteria
* Is experiencing an adverse event attributed to previous SSRI/SNRI use that has not been resolved at least one week prior to Baseline Visit.
* Has a history of seizure disorder.
* Has met criteria for substance abuse or dependence within 6 months prior to Baseline Visit.
* Currently using an antidepressant.
* Currently pregnant.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials, MD
Role: STUDY_CHAIR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GSK Clinical Trial Call Center
Birmingham, Alabama, United States
GSK Clinical Trial Call Center
Birmingham, Alabama, United States
GSK Clinical Trial Call Center
Fairfield, Alabama, United States
GSK Clinical Trial Call Center
Mobile, Alabama, United States
GSK Clinical Trial Call Center
Phoenix, Arizona, United States
GSK Clinical Trial Call Center
Little Rock, Arkansas, United States
GSK Clinical Trial Call Center
Little Rock, Arkansas, United States
GSK Clinical Trial Call Center
Anaheim, California, United States
GSK Clinical Trial Call Center
Anaheim Hills, California, United States
GSK Clinical Trial Call Center
Bellflower, California, United States
GSK Clinical Trial Call Center
Cerritos, California, United States
GSK Clinical Trial Call Center
Clovis, California, United States
GSK Clinical Trial Call Center
Encino, California, United States
GSK Clinical Trial Call Center
Petaluma, California, United States
GSK Clinical Trial Call Center
Riverside, California, United States
GSK Clinical Trial Call Center
Sacramento, California, United States
GSK Clinical Trial Call Center
Sacramento, California, United States
GSK Clinical Trial Call Center
San Francisco, California, United States
GSK Clinical Trial Call Center
Temecula, California, United States
GSK Clinical Trial Call Center
Vista, California, United States
GSK Clinical Trial Call Center
Colorado Springs, Colorado, United States
GSK Clinical Trial Call Center
Wilmington, Delaware, United States
GSK Clinical Trial Call Center
Wilmington, Delaware, United States
GSK Clinical Trial Call Center
Boynton Beach, Florida, United States
GSK Clinical Trial Call Center
Delray Beach, Florida, United States
GSK Clinical Trial Call Center
Fort Myers, Florida, United States
GSK Clinical Trial Call Center
Melbourne, Florida, United States
GSK Clinical Trial Call Center
Miami, Florida, United States
GSK Clinical Trial Call Center
Ocala, Florida, United States
GSK Clinical Trial Call Center
Atlanta, Georgia, United States
GSK Clinical Trial Call Center
Idaho Falls, Idaho, United States
GSK Clinical Trial Call Center
Gurnee, Illinois, United States
GSK Clinical Trial Call Center
Greenwood, Indiana, United States
GSK Clinical Trial Call Center
Lafayette, Louisiana, United States
GSK Clinical Trial Call Center
Lake Charles, Louisiana, United States
GSK Clinical Trial Call Center
New Orleans, Louisiana, United States
GSK Clinical Trial Call Center
Prince Frederick, Maryland, United States
GSK Clinical Trial Call Center
Springfield, Massachusetts, United States
GSK Clinical Trial Call Center
Excelsior Springs, Missouri, United States
GSK Clinical Trial Call Center
Kansas City, Missouri, United States
GSK Clinical Trial Call Center
Saint Charles, Missouri, United States
GSK Clinical Trial Call Center
St Louis, Missouri, United States
GSK Clinical Trial Call Center
Las Vegas, Nevada, United States
GSK Clinical Trial Call Center
Reno, Nevada, United States
GSK Clinical Trial Call Center
Blackwood, New Jersey, United States
GSK Clinical Trial Call Center
Mercerville, New Jersey, United States
GSK Clinical Trial Call Center
Princeton, New Jersey, United States
GSK Clinical Trial Call Center
Carrboro, North Carolina, United States
GSK Clinical Trial Call Center
Cary, North Carolina, United States
GSK Clinical Trial Call Center
Cincinnati, Ohio, United States
GSK Clinical Trial Call Center
Cincinnati, Ohio, United States
GSK Clinical Trial Call Center
Cleveland, Ohio, United States
GSK Clinical Trial Call Center
Independence, Ohio, United States
GSK Clinical Trial Call Center
Oklahoma City, Oklahoma, United States
GSK Clinical Trial Call Center
Eugene, Oregon, United States
GSK Clinical Trial Call Center
Downingtown, Pennsylvania, United States
GSK Clinical Trial Call Center
Bartlett, Tennessee, United States
GSK Clinical Trial Call Center
Cordova, Tennessee, United States
GSK Clinical Trial Call Center
Selmer, Tennessee, United States
GSK Clinical Trial Call Center
Conroe, Texas, United States
GSK Clinical Trial Call Center
Corsicana, Texas, United States
GSK Clinical Trial Call Center
Dallas, Texas, United States
GSK Clinical Trial Call Center
DeSoto, Texas, United States
GSK Clinical Trial Call Center
Fort Worth, Texas, United States
GSK Clinical Trial Call Center
Galveston, Texas, United States
GSK Clinical Trial Call Center
Richardson, Texas, United States
GSK Clinical Trial Call Center
Sugar Land, Texas, United States
GSK Clinical Trial Call Center
West Valley City, Utah, United States
GSK Clinical Trial Call Center
Lebanon, Virginia, United States
GSK Clinical Trial Call Center
Richmond, Virginia, United States
GSK Clinical Trial Call Center
Kirkland, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SB29060.833
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.